- Author:Michael Yeadon,Zuzana Diamant
- Publisher:CRC Press; 1 edition (November 12, 1999)
- Pages:528 pages
- Subcategory:Medicine & Health Sciences
- FB2 format1764 kb
- ePUB format1816 kb
- DJVU format1752 kb
- Formats:doc azw docx lit
Mobile version (beta).
Mobile version (beta). Lung Biology in Health & Disease Volume 139 New and Exploratory Therapeutic Agents for Asthma. Download (epub, 436 Kb). FB2 PDF MOBI TXT RTF. Converted file can differ from the original. If possible, download the file in its original format.
This comprehensive volume addresses the latest treatment strategies for asthma, keying in on the genetics and . Written by more than 20 leading international experts, New and Exploratory Therapeutic Agents for Asthma.
Written by more than 20 leading international experts, New and Exploratory Therapeutic Agents for Asthma.
New and Exploratory Therapeutic Agents for Asthma (Lung Biology in Hea. New and Exploratory Therapeutic Agents for Asthma (Lung Biology in Hea.
32. Kline JN: DNA therapy for asthma. Curr Opin Allergy Immunol 2002, 2:69–73. CrossRefGoogle Scholar. 33. Akinbami LJ, Schoendorf KC: Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 2002, 110:315–322.
New and Exploratory Therapeutic Agents for Asthma: Lung Biology in Health and Disease. Committee of Ministry of Health on "Pollution, Climate and Respiratory Health, Naples, Italy. Chairman Committee and Task Force on Air pollution, climate change and allergic respiratory diseases World Allergy Organization, Naples, Italy.
Molecular Biology of the Cell: Problems Book. Essential Cell Biology. The Biology of Cancer. Case Studies in Cancer. examines the role of monoclonal antibodies in allergy and asthma. describes functions and pharmacokinetic profiles of bronchodilator 2 agonists, anticholinergics, and inhaled. investigates the controversy of different types of asthma.
By Michael Yeadon, Zuzana Diamant. Containing over 2000 bibliographic citations and a concise introduction for each chapter, New and Exploratory Therapeutic Agents for Asthma is indispensable for pulmonologists, pediatricians, physiologists, immunologists, allergists, pharmaceutical industry scientists, primary care physicians, and medical s.
New techniques in RT, including hyperfractination and 3-dimensional .
New techniques in RT, including hyperfractination and 3-dimensional conformal RT (3-DCRT), have changed conventional RT, which has been regarded as standard modality for locally advanced NSCLC. Introduction of cisplatin into chemotherapeutic regimens for NSCLC has changed the status of chemotherapy to standard therapy for patients with stage IV or stage IIIb with effusion. Gene therapy is a novel therapeutic approach based on molecular oncology and tumour immunology. The practical contribution of gene therapy to clinical oncology is still minimal